Blood and Bone Marrow Basics
A patient's guide to understanding blood and bone marrow. Blood is a "circulating organ" of the body. It is composed of many different types of cells that are carried through the body in plasma. The blood helps to…
Paroxysmal Nocturnal Hemoglobinuria (PNH)
How to Evaluate the Quality of Online Health Information
As you search online, you will find websites from many different sources. These seven questions will help you analyze and evaluate the credibility of each site you review. Many of these details can also be found in a…
Community Connections
Would you like to connect with other patients and families in your own town? Learn how you can participate in our volunteer-led Community Connections-local groups designed to inspire the creation of community…
Your Guide to Understanding PNH (Paroxysmal Nocturnal Hemoglobinuria)
Get the facts and information you need on paroxysmal nocturnal hemoglobinuria (PNH) in this patient guide. Learn about the several types of PNH blood cells, treatments, how to take an active role in your care, and tips…
Eileen Hu, MD, PhD
Institution
UT Southwestern Medical Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
About
Dr. Eileen Hu is an internal medicine specialist located in Dallas, TX, who completed her education at Ohio State University College of Medicine in 2022 and is currently undergoing her residency in internal medicine at the University of Texas Southwestern Medical Center, projected to finish in 2028. She has contributed to several publications focusing on leukemia, including works in Nature Genetics, Cell Reports, and Blood, with citations indicating engagement from the scientific community. Her research primarily revolves around acute myeloid leukemia, drug sensitivities, and cellular
Jamie L Koprivnikar, MD
Institution
John Theurer Cancer Center - Hackensack
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
About
Dr. Jamie Koprvinikar specializes in hematology and medical oncology and is board certified in both. She also holds a board certification in internal medicine. Dr. Koprivnikar received her medical degree from the Sidney Kimmel Medical College, formerly Jefferson Medical College of Thomas Jefferson University, in Philadelphia, PA. She completed her internal medicine residency at MedStar Georgetown University Medical Center in Washington, DC. She then completed a fellowship in hematology and oncology, also at MedStar Georgetown University Medical Center. She was chosen to serve as chief fellow
2025 EHA Update: Aplastic Anemia and PNH
Topic(s)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Aplastic Anemia
Presenter(s)
Phil Scheinberg, MD
In this webinar, Dr. Phillip Scheinberg will discuss the latest research presented at EHA about aplastic anemia and PNH. This is an advanced presentation. There will be a Q & A session and questions can be submitted in advance to help@aamds.org.
Managing PNH Complications from the Chapel Hill Patient and Family Conference
Topic(s)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Presenter(s)
Srinivasa Reddy Sanikommu, MD
In this recording, Dr. Srinivasa Sanikommu discusses complications that can occur during a PNH patient's lifetime and the treatment options available to patients.
Transplant and GVHD from the 2025 Chapel Hill Patient and Family Conference
Topic(s)
Bone Marrow Transplant
Presenter(s)
Jeremy A. Meier, MD, PhD
In this recording, Dr. Jeremy Meier discusses the journey of a transplant (before, during and after) and potential management of GVHD.
Brandi Reeves, MD
Institution
University of North Carolina at Chapel Hill School of Medicine
Physician Status
accepting new patients
Primary Disease Area of Focus
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
About
I am a physician-scientist specializing in myeloproliferative neoplasms (MPN), bone marrow failure syndromes, lower risk myelodysplastic syndromes (MDS), and clonal hematopoiesis. I lead our MPN program, which was established in 2019 and provides clinical and research expertise for MPN patients. My research primarily focuses on mechanisms of thrombosis in MPN, with a goal to improve MPN care by individualizing thrombosis risk stratification and by finding better treatments to prevent thrombosis. I am also dedicated to training the next generation of physicians and am involved in medical